71 results

• Nevro SCS Lawsuits Warrant Centralization in New MDL: Motion

  July 8, 2026

  Irvin Jackson

  Plaintiffs have requested that the Judicial Panel on Multidistrict Litigation consolidate all Nevro spinal cord stimulator lawsuits in the Central District of California for pretrial procedures.

• Proclaim Spinal Cord Stimulator Lawsuit Follows Infection, Battery Migration Problems

  July 6, 2026

  Irvin Jackson

  A Texas man's lawsuit claims the electrodes and battery of an Abbott spinal cord stimulator tried to push out of his skin, resulting in a severe infection and the need for surgical removal.

• MDL Sought for Abbott Spinal Cord Stimulator Lawsuits

  June 29, 2026

  Irvin Jackson

  A panel of federal judges has been asked to review a proposal that would consolidate all federally-filed Abbott Laboratories spinal cord stimulator lawsuits before one judge for pretrial proceedings.

• Abbott Spinal Cord Stimulator Battery Problems Led to Repeat Surgeries, Lawsuit Claims

  June 16, 2026

  Michael Adams

  Four plaintiffs allege Abbott spinal cord stimulator battery problems, painful malfunctions and other device failures caused worsening symptoms and repeat surgeries after the company made hundreds of changes to its implant systems.

• Lawsuit Claims Abbott, Boston Scientific SCS Pre-Market Approval Supplements Caused Permanent Injuries

  April 29, 2026

  Michael Adams

  A Florida woman’s lawsuit alleges that Abbott Laboratories and Boston Scientific altered their SCS device batteries, firmware and stimulation features without adequate safety testing approved by the FDA.

• FreeStyle Libre 3 Lawsuits Mount as FDA Issues Class I Glucose Monitor Recall

  February 5, 2026

  Michael Adams

  Federal health officials have issued a Class I recall of certain Abbott FreeStyle Libre 3 and Libre 3 Plus glucose monitor sensors after internal testing found the devices could display dangerously inaccurate low blood sugar readings for extended periods without alerting users.

• FDA Warns 3 Million FreeStyle Libre 3 and Libre 3 Plus Sensors Impacted by Massive Abbott Recall

  January 19, 2026

  Michael Adams

  Federal regulators announced a Class I recall of about 3 million Abbott FreeStyle Libre 3 and Libre 3 Plus sensors, as emerging lawsuits claim the faulty devices triggered unnecessary insulin use and dangerous hypoglycemia after multiple deaths were linked to inaccurate readings.

• Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings

  January 15, 2026

  Irvin Jackson

  A new Abbott CGM lawsuit seeks class action status for all those who purchased the FreeStyle Libre 3, which was recalled in November for providing inaccurate glucose data.

• Abbott Libre 3 Class Action Lawsuit Claims CGM Defects Could Result in Serious Injury

  January 8, 2026

  Irvin Jackson

  Two plaintiffs are pursuing a class action lawsuit against Abbott Laboratories after last year's recall of its Freestyle Libre 3 continuous glucose monitoring devices due to inaccurate readings.

• Abbott FreeStyle Libre 3 Recall Issued After Faulty Glucose Sensor Readings Linked to Multiple Deaths

  November 26, 2025

  Darian Hauf

  Abbott has issued a recall for about 3 million FreeStyle Libre 3 glucose sensors, warning that some units may report dangerously low glucose readings that could place users at serious risk.